Applications for the 2025 Childhood Cancer Survivor Study Career Development Award are now open! If you're an early-career investigator or trainee passionate about childhood cancer survivorship, apply by October 7, 2024. This award provides a unique opportunity to delve into scientific research that could shape future treatment protocols and interventions, aiming to increase survival rates and reduce adverse health outcomes. Recipients of this award will gain valuable insights into the long-term effects of cancer, contributing to meaningful advancements in the field. “This award gave me the opportunity to learn from incredible mentors who continue to mentor me to this day and helped motivate my research program,” recalls Cindy Im, PhD, Junior faculty awardee in 2019. With the support of the CCSS Career Development Award, Dr. Im researched late effects risk prediction and gained the confidence to apply for her first NIH grant. Today, she is an assistant professor at the University of Minnesota.
St. Jude Children's Research Hospital’s Post
More Relevant Posts
-
🎉 CELEBRATING CCR CAREERS: David D. Roberts, Ph.D., a biochemist who identified a new pathway that controls cell responses to stress and developed approaches to improve cancer therapy by shutting it down, announces his retirement from the NCI. ➡ Read the full feature here: https://lnkd.in/gjtfG5ge "Think about how your research skills can be applied across medical disciplines. Basic researchers should attend clinical seminars and contemplate what unanswered questions could be addressed using their knowledge and skills. I encourage young investigators to explore the diverse core facilities within CCR and NIH and learn about the available support for patenting and technology transfer that can facilitate the commercial development of your lab discoveries." National Cancer Institute (NCI), National Institutes of Health (NIH): Intramural Research Program (IRP) #CancerResearch #Biochemistry #Retirement #Innovation #Medicine
To view or add a comment, sign in
-
I'm happy to share our new publication, a significant milestone in my PhD journey. I'm grateful for the support and guidance of my mentor and colleagues, this achievement would not have been possible without your contributions. https://lnkd.in/eW4gu3U7 #Research #CancerResearch #LiverCancer #ScientificResearch
To view or add a comment, sign in
-
🔍The Phase4AI-EUProject partners revealing is continuing 🚀 👉 Today, we present KU Leuven. ✅Profile: KU Leuven, founded in 1834, is a prominent Belgian research university located in Leuven, Belgium. KU Leuven is the largest university in Belgium and the BENELUx. In 2021–22, more than 65,000 students were enrolled, with 21% being international students. Renowned for its academic excellence, it consistently ranks among the top universities globally. KU Leuven is recognized for its diverse range of programs, cutting-edge research, and a commitment to fostering innovation. With a rich history and a focus on interdisciplinary collaboration, it remains a leading institution in education and research. Since 2016 KU Leuven is leading the list of the most innovative universities of Europe. ✅Role: In the context of Phase IV KU Leuven will be mainly leading 2 different tasks and a use-case. We will be responsible for the creation of metrics for quantification of the utility and privacy of the synthetically generated data and we will also lead the Prostate Cancer use case where we will try to explore Real World Data in order to predict different outcomes of interest for patients with prostate cancer. 🌐 Explore KU Leuven: https://lnkd.in/dU6mbBiM #healthcare, #machine_learning, #data_analytics, #data_protection, #synthetic_data, #multiparty_computation
To view or add a comment, sign in
-
Meet our CAPAC 2024 trainee, Valeria M. Schleier Albino! Valeria recently completed a master’s degree in environmental health from the University of Puerto Rico Medical Sciences Campus. During the summer, Valeria worked under the guidance and mentorship of Dr. Magaly Martinez Ferrer at Comprehensive Cancer Center. They have been conducting extensive research on the effects of Methyl Jasmonate (MJ) on cancer cells, focusing specifically on the A-253 cell line, which is derived from human salivary gland carcinoma. Methyl Jasmonate, a plant hormone involved in stress response and defense mechanisms, has demonstrated significant anti-cancer properties in various studies. The research aims to elucidate the underlying mechanisms by which MJ induces apoptosis (programmed cell death) and inhibits proliferation in cancer cells. #CancerResearch #CancerPrevention
To view or add a comment, sign in
-
🌟Meet our Summer Research Fellowship scholar, Anika Henning! 🌟 Anika is a fourth-year student at the University of Wisconsin-Lacrosse. Let's take a sneak peek into how she enjoys her SRF experience. Here's the Q&A: Q1. What initially drew you to apply for the Mayo Clinic Summer Research Fellowship program? A1. Being from Rochester, MN, I have always been interested in being a part of Mayo Clinic. Last summer, I worked in the Hematopathology lab where I saw the clinical side of Mayo Clinic. I was also interested in the research side of Mayo Clinic. Since I plan to get my Ph.D. and work in research as a career, this was the perfect place and program to expand my horizons in the field of research. Q2. What specific research project are you working on during the fellowship? A2. During my fellowship, I am working on the role of extracellular vesicles in Type 1 and Type 2 diabetes. These extracellular vesicles act as modes of communication between cells. We are interested in how this cell-to-cell communication plays a role in Type 1 and 2 diabetes. We can look at this by tagging a protein (CD63) on the surface of cells in islets. Q3. Can you describe a typical day in the life of a Summer Research Fellowship participant? A3. A typical day in the life of a Summer Research Fellowship participant can vary depending on what needs to be done. A day where I am doing an experiment can get lengthy. However, there is usually some downtime during incubations where I will read papers, catch up on emails, or write in my lab notebook. If I am doing data analysis, the day is usually shorter, but there is no downtime. Many days include meetings or events. To make the most of my experience here at Mayo Clinic, I schedule meetings and shadowing experiences with people and subjects I find interesting. I either schedule these very early in the day or late in the afternoon as to not interfere with experiments. On days where I have an SRF event to attend, I make sure to plan out my experiments around this time. You will learn how to plan and be time efficient! Q4. What has been the most challenging part of your research, and how are you addressing it? A4. The most challenging part of my research is catching up with the lab. You may know nothing about the lab you are in and will need to do a lot of reading to get caught up with the lab. Everyone has had to do this at one point or another, so do not feel like you are behind! To manage this, I asked my mentor before the program started how I should prepare and she sent papers which I read before I even stepped foot in the lab. This made the first week less overwhelming. To learn more about the Mayo Clinic Summer Research Fellowship Program, visit our website: https://lnkd.in/grKQegG #MayoClinic #SummerResearchFellowship
To view or add a comment, sign in
-
👉 I SPEAK SCIENTISH 👈 | life scientist - scientific translator and reviewer - CPD trainer in science and communication || 👉 👀 tailored research dissemination and communication workshops for MSCA Doctoral Networks
It’s an interesting feeling when your history comes full circle. 🔄 A few years ago (Oh, quite a few 😉 ), when I was taking my first steps in real lab work as a Ph.D. student, at IARC*, I discovered the term "liquid biopsy". It carried an intriguing mystery and a promise, or at least hope, of improving cancer diagnosis. It meant lots of meticulous experiments and a laborious learning process under the guidance of brilliant mentors. Linkedin was not there yet, let alone Zoom conferences. Many researchers stayed in their expert bubbles, far from the general public. 🔄 🔄 Earlier this month, these "quite a few years" later, I found myself running a communication workshop for doctoral candidates of the ColoMARK MSCA* Network who all work on liquid biopsy! 🙃 One of the participants is doing her Ph.D. at the very same IARC. Now it’s their turn to work, learn, and hope under brilliant mentors. Their research comes thousands of specialist papers after mine. But they shall not confine themselves to these specialist bubbles. Social media are everywhere, videoconferencing has become a banality, curious eyes and sharp ears are close. The world has changed. 🔄 🔄 Also mine. I’m not at the bench anymore. But still following close. Sometimes editing one of those specialist papers. Sometimes making science simple for lay audience. Other times yet, showing the way to young researchers like the ColoMARKers, so that they can convince the world that 👉 their research counts. 🔔 Because some things do not change. Whatever people don’t see, they won’t believe. Whatever they don’t understand, they will fear. The means of communicating about research have evolved, but not the necessity to make the world hear your voice. 🔄 HAPPY POSTING, ColoMARKers! 😀 🤞 #ColoMARK ********************************************************************* #MSCA #SciencetothePoint #sciencecommunication *IARC: International Agency for Research on Cancer (WHO) **MSCA:: Marie Skłodowska-Curie Actions (part of Horizon Europe, an EU’s programme for doctoral and postdoctoral training) [I’ve written this post in English. If you see it in another language, it has been automatically (and likely poorly) translated by Linkedin.]
To view or add a comment, sign in
-
NEWS: Construction Underway for Michigan State University + Henry Ford Health Biomedical Research Center -- Michigan State University (MSU) and Henry Ford Health have joined forces to construct the $335 million Henry Ford Health + Michigan State University Research Center, which will house 84 principal investigators and their research teams focused on cancer, neuroscience, infectious diseases, immunology, and public health. The first floor will accommodate a large core lab including an imaging suite. An entire floor will be dedicated to the Nick Gilbert Neurofibromatosis Research Institute. At 335,000 sf and seven stories, it will be will be MSU’s largest research facility. As part of a 30-year partnership begun in 2021, the center will be owned by MSU on land leased from Henry Ford Health, and operated jointly by both institutions. The venture is part of a $3 billion development group that includes the Detroit Pistons basketball organization. The “Future of Health” project will feature a new hospital tower and 600 units of mixed-income housing. Designed by ZGF Architects with Barton Malow as the construction manager, the facility is expected to open in 2027. https://lnkd.in/eRX6QcSU #Collaboration #GroundBreaking #InterdisciplinaryResearch #Biomedical #Healthcare #HigherEducation #ResearchandDevelopment
Construction Underway for Michigan State University + Henry Ford Health Biomedical Research Center
tradelineinc.com
To view or add a comment, sign in
-
What drives the laureates, who inspires them, and what are their goals for the future? To get to know this years’ laureates, we have asked them three questions. These are Kevin ten Haaf’s answers: What question is central to your research? How we can best identify people at high risk for a particular disease and detect the disease early in an efficient way. What is your personal motivation for your research subject? My grandfather unfortunately died of lung cancer when I was young. When I came across a PhD position where I had the opportunity to apply the knowledge from my studies in econometrics to help patients with lung cancer it really appealed to me. The issues are challenging, and it gives me satisfaction to use statistics to help improve health care. What are your future research goals? In the near future, I hope to expand my research field even further into personalized screening, treatment and surveillance (post-treatment monitoring studies), not only for lung cancer but also for head and neck cancer, bladder cancer and cardiovascular disease. #HeinekenPrizes #interview #laureates #science
To view or add a comment, sign in
-
Prof researching blood cells including cancers, stem cells and microenvironment. Recipient of two cochlear implants, #DisabledinSTEMM. Advocate of DEI & improving retention of all underrecognised people in the workplace.
I am very proud of Gavin receiving an SVI Rising Star award for his research investigating how cancer therapies alter the bone marrow microenvironment and, in turn, the support of blood cell production. Cancer therapies cause significant side effects in patients, and one common side effect is low blood cell counts. These low blood counts can be life-threatening and cause significant delays in the ability of the patient to receive subsequent cancer treatments in a timely manner. In turn, this can allow the cancer cells time to grow back and become resistant to the cancer therapies. We have been working on understanding why this occurs and to develop methods to improve blood cell counts in cancer patients since 2008, when I established my lab at SVI. Funding from Leukaemia Foundation enabled us to commence this ambitious project and we were also fortunate to receive subsequent funding from National Health and Medical Research Council (NHMRC) for some of this work. My first postdoctoral fellow, Dr Maria Askmyr was a key contributor to the early studies and achieved a large amount of data in just 2 years in my lab- I miss you Maria ♥️ Funding is an essential requirement for research- the more $ you have the more you can advance your research! Philanthropy support such as the SVI Rising Star award (and other donations to support research projects) are very important in progressing research. I am very proud of what we have achieved and we are now progressing to identifying therapies to improve blood cell counts in cancer patients (and publish some very exciting results, including a large amount of data that Maria significantly contributed to!). We thank Cancer Australia for contributing to this research as well, supporting Gavin’s research in the last 2 years, significantly advancing one of our goals, to identify how to improve platelet production in cancer patients. This research program was started in my lab because one of my closest friends was diagnosed with breast cancer. I recognised during the course of her treatment that her ability to receive her next round of cancer treatment was significantly affected by her blood cell counts. We know that cancer therapies can affect maturing blood cells, which are rapidly dividing (like cancer cells!). However the blood-forming stem cells are spared by cancer treatments. So the missing link was why it takes so long for the blood cells to recover (and in some cases, they never recover to normal levels). We now know that missing link is changes occurring in the bone marrow microenvironment, which is the factory for blood cells. Sadly, my friend Carla passed away in 2013. I miss her very much and remain in contact with her sisters, including Cynthia Hartwig This project is dedicated to Carla’s memory, and in future we hope that her cancer journey will lead to improvements in blood cell counts in many cancer patients whose blood cells are affected by their cancer treatment. That will be Carla’s legacy ♥️
🌟 Meet SVI Rising Star Award Recipient: Dr Gavin Tjin Dr Gavin Tjin is microscopist, using his passion for microscopic techniques to solve biological questions – including how cells interact with their environment and how disease and treatment can alter these interactions. He works in SVI's Stem Cell Regulation Lab with Lab Head, Professor Louise Purton. Gavin has always been interested in learning about biology and medicine, and studied Medical Science in his undergraduate at the University of Sydney. His passion for understanding the biological mechanisms behind diseases grew further during his PhD. Gavin's goal is to improve our understanding and discovering novel solutions to treat diseases. "It is an honour for me to receive this Rising Star award and I am very grateful to the SVI foundation for giving me this opportunity. The Rising Star award is a significant milestone in my journey as a researcher and it will allow me to further my study of the bone marrow microenvironment and how they are affected by cancer therapies. It is a great boost to my career and morale as a researcher." Find out how you can support our Rising Stars here: https://lnkd.in/gxtvqa8t
To view or add a comment, sign in
-
This webinar series is proving really useful. Get to know what facilities and research activities are available to engage with at UCL
📢 [Join us on 26 June] Webinar: Overview of UCL Genomics core facility During this webinar, Dr Mark Kristiansen, will provide an overview of the comprehensive service provision currently offered by the facility, its operational model, and how you can access and collaborate with UCL Genomics. This webinar is part of the webinar series by the UCL Therapeutic Innovation Networks (TINs) to highlight UCL’s Research Infrastructure and Capabilities that enable effective translation of research toward patient/public benefit. The series aims to encourage multidisciplinary collaborations within and beyond UCL. Academics from the UCL biomedical community are invited to share subjects of interest based on their research expertise and interact with research fellows. Date : Wednesday 26 June 2024 Time : 1300 - 1345 Venue : Online Open to: All Speaker: Dr Mark Kristiansen, Head of UCL Genomics, UCL Chaired by: Dr Robert Hynds, GOS Institute of Child Health, Developmental Biology and Cancer and Regenerative Medicines Therapeutic Innovation Network committee member Register now: bit.ly/3VrLS5x Full schedule of UCL’s Research Infrastructure and Capabilities Series: bit.ly/46q4PaW #TranslationalResearch #TranslatingUCLScience #Collaborations #UCLResearchFacilities
To view or add a comment, sign in
81,608 followers
More from this author
-
Progress in HIV/AIDS Research and Treatment
St. Jude Children's Research Hospital 1y -
St. Jude is changing the way patients education resources are delivered
St. Jude Children's Research Hospital 1y -
Encouraging HPV Vaccination as Cancer Prevention in Rural Communities
St. Jude Children's Research Hospital 1y